Rachel Tompa, PhD[email protected]HomeNew hope for patients with hard-to-treat head/neck cancersUsing a technique that looks for genes that tumor cells need to survive, Seattle researchers have identified a potential new drug target for a class of difficult-to-treat head and neck cancers, according to a new study in Clinical Cancer Research.August 19, 2014Page 1 of 1Top StoriesRegulatory UpdatesBreaking news: Hearing reveals end of fluoride supplements may be nearThe early hours of a U.S. Food and Drug Administration hearing held on July 23 to collect feedback on concerns associated with prescription fluoride supplements for kids reveal the future of the cavity-fighter may be in trouble.Dental PracticeDig uncovers tooth-adorned baby carriersOral-Systemic LinkU.S. adults associate these dental problems with poor healthSmile DesignClinical tip: How one dentist uses platelet-rich fibrinSponsor ContentJoin Us July 24 at 8 p.m. ET
